The studies presented provide preliminary evidence that CD8-targeted PET imaging can be used to evaluate immune response by detecting CD8+ cell infiltration into tumors during oHSV immunotherapy in orthotopic glioma tumors in syngeneic mice. The gene discussed is CD8A; the disease is glioma.